Remschmidt Helmut
Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Universität Marburg, Hans-Sachs-Str. 4-6, 35033 Marburg, Germany.
Eur Child Adolesc Psychiatry. 2005 May;14(3):127-37. doi: 10.1007/s00787-005-0439-x.
A Global ADHD Working Group of experienced clinicians and researchers was gathered to review the latest evidence, discuss current best practice in the treatment of attention-deficit/hyperactivity disorder (ADHD), and make a statement based on consensus. The statement aims to re-affirm ADHD as a valid disorder that exists across different cultures, has a significant global impact, and should be diagnosed and effectively treated wherever it occurs. ADHD is one of the most common neurobehavioural disorders of childhood and impacts on many aspects of development, including social, emotional and cognitive functioning, in the home and school environment. Although these findings are from developed countries, the impact in developing countries is likely to be similar. There is strong supportive evidence for the validity of ADHD as a syndrome with neurobiological aspects, and complex genetic factors are primarily implicated in the aetiology. Accurate diagnosis and measurement of impairment is important to enable appropriate and successful management of symptoms. ADHD is a persistent condition that needs to be treated and monitored over time. The evidence supporting medication-based interventions (such as methylphenidate) is strong and consensus treatment algorithms to guide the multimodal treatment of ADHD, alone and in combination with common comorbidities, are suggested.
一个由经验丰富的临床医生和研究人员组成的全球注意力缺陷多动障碍（ADHD）工作组齐聚一堂，回顾最新证据，讨论当前治疗注意力缺陷/多动障碍（ADHD）的最佳实践，并达成共识发表声明。该声明旨在重申ADHD是一种在不同文化中都存在的有效疾病，对全球有重大影响，无论在何处出现都应进行诊断和有效治疗。ADHD是儿童期最常见的神经行为障碍之一，会影响家庭和学校环境中包括社交、情感和认知功能在内的许多发展方面。尽管这些发现来自发达国家，但在发展中国家的影响可能类似。有强有力的证据支持ADHD作为一种具有神经生物学特征的综合征的有效性，复杂的遗传因素主要与病因有关。准确诊断和评估损害程度对于实现症状的适当和成功管理很重要。ADHD是一种需要长期治疗和监测的持续性疾病。支持基于药物的干预措施（如哌甲酯）的证据很充分，并建议采用共识治疗算法来指导ADHD的多模式治疗，包括单独治疗以及与常见共病联合治疗。
